GSK-3 beta inhibition and prevention of mitochondrial apoptosis inducing factor release are not involved in the antioxidant properties of SB-415286.
Yeste-Velasco, Marc
GSK-3 beta inhibition and prevention of mitochondrial apoptosis inducing factor release are not involved in the antioxidant properties of SB-415286. [electronic resource] - European journal of pharmacology Jul 2008 - 239-43 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0014-2999
10.1016/j.ejphar.2008.04.019 doi
Aminophenols--pharmacology
Animals
Antioxidants--pharmacology
Apoptosis Inducing Factor--metabolism
Cells, Cultured
Cerebellum--drug effects
Glycogen Synthase Kinase 3--antagonists & inhibitors
Glycogen Synthase Kinase 3 beta
Lithium--pharmacology
Maleimides--pharmacology
Neuroprotective Agents--pharmacology
Rats
Rats, Sprague-Dawley
GSK-3 beta inhibition and prevention of mitochondrial apoptosis inducing factor release are not involved in the antioxidant properties of SB-415286. [electronic resource] - European journal of pharmacology Jul 2008 - 239-43 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0014-2999
10.1016/j.ejphar.2008.04.019 doi
Aminophenols--pharmacology
Animals
Antioxidants--pharmacology
Apoptosis Inducing Factor--metabolism
Cells, Cultured
Cerebellum--drug effects
Glycogen Synthase Kinase 3--antagonists & inhibitors
Glycogen Synthase Kinase 3 beta
Lithium--pharmacology
Maleimides--pharmacology
Neuroprotective Agents--pharmacology
Rats
Rats, Sprague-Dawley